Evogene (EVGN) said Thursday that it is collaborating with Alphabet's (GOOG, GOOGL) Google Cloud to create a new foundation model for designing small molecules.
The company said it will use Google Cloud's Vertex AI, GPUs, and Cloud Storage to access the computational power and storage needed to develop the new artificial intelligence model. The collaboration aims to improve Evogene's ChemPass AI technology, which helps discover and develop innovative products based on small molecules.
The main goal of the initiative is to advance drug development, sustainable crop protection, and support other life-science applications, the company added.
Price: 2.33, Change: -0.01, Percent Change: -0.43
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.